Jeffrey Nau

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease

David Wirta, Patrick Vollmer, James D. Paauw et al. · Ophthalmology · 2021 · 101 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +17

Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration

Marcos Pereira de Ávila, Michel Eid Farah, Arturo Santos et al. · British Journal of Ophthalmology · 2008 · 90 citations

Medicine, Ophthalmology, Vision Science +17

Epimacular Brachytherapy for Neovascular Age-related Macular Degeneration

Pravin U. Dugel, Judith D. Bebchuk, Jeffrey Nau et al. · Ophthalmology · 2012 · 89 citations

Medicine, Ophthalmology, Surgery +12

TWELVE-MONTH SAFETY AND VISUAL ACUITY RESULTS FROM A FEASIBILITY STUDY OF INTRAOCULAR, EPIRETINAL RADIATION THERAPY FOR THE TREATMENT OF SUBFOVEAL CNV SECONDARY TO AMD

Marcos P. Ávila, Michel Eid Farah, Arturo Santos et al. · Retina · 2009 · 66 citations

Medicine, Ophthalmology, Vision Science +17

ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease

David Wirta, Gail Torkildsen, Blair Boehmer et al. · Cornea · 2021 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17